Tumor progression is a complex process which involves tumor-host interactions through mul tiple cellular and molecular factors of the tumor microenvironment. Evidence has amassed that diverse stromal, vascular, and inflammatory cells, which make up the tumor microenvironment, are essential for various aspects of macroscopic tumor growth, maintenance, invasion, and an giogenesis. Thereby, multiple cell populations have the capability to influence the initial re sponses to therapy, tumor recurrence, and drug resistance (Dave et al., 2004; Galon et al., 2006; Andreu et al., 2010) . However, tumors are able to create an immunosuppressive micro environment to escape immune surveillance and promote tumor development (Coussens and Werb, 2002; Balkwill and Coussens, 2004) . It has been reported that CD4 + CD25 + regulatory T (T reg) cells, which express the T reg cellspecific transcription factor Foxp3-thereby defined as CD4 + CD25 + T reg cells of Foxp3 + T reg cells in this study-participate in anti tumor immune responses by dampening T cell immunity to tumorassociated antigens and to be the main obstacle tempering successful immuno therapy and active vaccination. In different mouse models, but also in patients with various cancers,
Infiltration of Foxp3 + regulatory T (T reg) cells is considered to be a critical step during tumor development and progression. T reg cells supposedly suppress locally an effective anti-tumor immune response within tumor tissues, although the precise mechanism by which T reg cells infiltrate the tumor is still unclear. We provide evidence that Neuropilin 1 (Nrp-1), highly expressed by Foxp3 + T reg cells, regulates the immunological anti-tumor control by guiding T reg cells into the tumor in response to tumor-derived vascular endothelial growth factor (VEGF)
. We demonstrate for the first time that T cell-specific ablation of Nrp-1 expression results in a significant breakdown in tumor immune escape in various transplantation models and in a spontaneous, endogenously driven melanoma model associated with strongly reduced tumor growth and prolonged tumor-free survival. Strikingly, numbers of tumor-infiltrating Foxp3 + T reg cells were significantly reduced accompanied by enhanced activation of CD8 + T cells within tumors of T cell-specific Nrp-1-deficient mice. This phenotype can be reversed by adoptive transfer of Nrp-1 + T reg cells from wild-type mice. Thus, our data strongly suggest that Nrp-1 acts as a key mediator of Foxp3 + T reg cell infiltration into the tumor site resulting in a dampened anti-tumor immune response and enhanced tumor progression.
but not in mice that received CD4 + CD25  T cells, CD8 + T cell immunity against tumor antigens was abolished (Turk et al., 2004; Antony et al., 2005) . Collectively, these studies clearly demon strate the importance of CD4 + CD25 + T reg cells in tumor immunity. However, by which mecha nism CD4 + CD25 + T reg cells infiltrate into the tumor to locally suppress an effective antitumor immune response remains elusive. To develop better immunotherapeutic strategies, it is important to identify the mechanisms underlying the recruit ment and interactions between tumor cells and cells of the immune system.
Recently, we have identified the type I trans membrane protein Neuropilin 1 (Nrp1) to be highly expressed by CD4 + CD25 + T reg cells and showed that CD4 + Nrp1 + T cells are able to suppress prolif eration of naive T cells upon stimulation in vitro in contrast to CD4 + Nrp1  T cells (Bruder et al., 2004) . Overexpression of the T reg cell-specific transcrip tion factor Foxp3 led to the induction of Nrp1 expression in CD4 + CD25  T cells, suggesting that Nrp1 ex pression is regulated by Foxp3 (Bruder et al., 2004; Loser et al., 2005) . Moreover, it was proposed that Nrp1 expressed by CD4 + CD25 + T reg cells plays a crucial role in the forma tion of longlasting interactions of T reg cells with immature DCs (Sarris et al., 2008) , and Tordjman et al. (2002) described Nrp1 as player in the establishment of cellular contacts between naive T cells and DCs involved in T cell activation. Originally, Nrp1 was described to be expressed in the developing Xenopus laevis nervous system (Fujisawa et al., 1995) , but Nrp1 expression has also been observed in other cells like DCs, endothelial cells, and tumor cells (Kawakami et al., 2002; Tordjman et al., 2002; Bielenberg et al., 2006) . The absence of a functional Nrp1 receptor leads to embryonic lethality be cause of impaired heart development and defective endothelial cell migration, resulting in vessel enlargement and defects in large numbers of CD4 + CD25 + T reg cells have been found in the circulation or in the tumor microenvironment (Zou, 2006) . Importantly, the number of CD4 + CD25 + T reg cells present in tumors and, in particular, decreased ratios of CD8 + T cells to T reg cells, correlate with poor prognosis in pa tients with breast, gastric, and ovarian cancer (Nishikawa and Sakaguchi, 2010) . Furthermore, depletion of CD4 + CD25 + T reg cells by administration of antiCD25 antibodies inhibits tumor growth, demonstrating that T reg cells indeed promote tumorigenesis (Onizuka et al., 1999; Shimizu et al., 1999) and potentially modulate the clinical course of the disease. A direct link between T reg cells and reduced tumor immunity was provided by adoptive transfer experiments. Tumorspecific CD8 + T cells were transferred with either CD4 + T cells lack ing the CD4 + CD25 + compartment or CD4 + CD25 + T reg cells to melanomabearing mice. In mice that received T reg cells, Nrp-1KO) and WT mice (white bars; Nrp-1WT) by flow cytometry. Representative dot plots from one experiment are depicted on the left and mean values ± SEM from n = 7-11 mice analyzed in three independent experiments are shown on the right. (E) Nrp-1 expression on CD11c + , CD11b + , CD8 + , CD19 + , and NK1.1 + splenocytes isolated from Nrp-1KO mice (black bars) and Nrp-1WT mice (white bars) analyzed by flow cytometry. Results from two independent experiments (n = 7-8 mice) are depicted as mean ± SEM. ***, P < 0.001 (Student's t test).
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correct migration of the somata of facial motor neurons (Schwarz et al., 2004) . Thus, a fundamental function of Nrp1 is the regulation of cell motility toward a VEGF gradient.
In the present study, we demonstrate in several transplantation models, but also in a spontaneous, endogenously driven murine melanoma, that knockdown of Nrp1 expression in T reg cells resulted in delayed tumor formation and progression. This reduced tumor outgrowth was strongly dependent on a decreased infiltration of Foxp3 + T reg cells into the tumor site which, in turn, is mediated by tumorderived VEGF attraction. Importantly, the im paired tumor growth in T cell-specific Nrp1-deficient mice could be restored by adoptive transfer of Nrp1 + T reg cells from WT mice. These results highlight the relevance of Nrp1 on Foxp3 + T reg cells as a key mediator of the immunological antitumor control.
RESULTS
Delayed tumor growth in Nrp-1 flox/flox × CD4-cre mice CD4 + Foxp3 + T reg cells play a critical role in tumor immunity by suppression of an appropriate antitumor immune response. A few years ago, we identified Nrp1 to be specifically ex pressed by CD4 + CD25 + T reg cells in contrast to CD4 + CD25  naive T cells and in vitro activated T cells (Bruder et al., 2004;  vascular sprouting (Kitsukawa et al., 1997; Kawasaki et al., 1999; Jones et al., 2008) . In addition, it has been demon strated that Nrp1 acts as a receptor for the vascular endo thelial growth factor (VEGF) to regulate vascular development during embryogenesis (Soker et al., 1998) . VEGF and its receptors are also essential during postnatal formation of new blood vessels (Chen et al., 2005) , and VEGF expres sion is associated with increased angiogenesis and advanced stage disease in a variety of solid tumor types (Takahashi et al., 1995; Price et al., 2001) . The role of Nrp1 in VEGF signaling was originally studied using porcine aortic endo thelial cells. Coexpression of Nrp1 and VEGF receptor 2 (VEGFR2) in these cells enhances VEGF binding and che moattraction toward VEGF (Soker et al., 1998) . Subsequent investigations using human endothelial cells demonstrated that Nrp1 alone, without VEGFR2 expression, can medi ate migration toward VEGF and endothelial cell adhesion to extracellular matrix (Wang et al., 2003; Murga et al., 2005; Pan et al., 2007) . It has been demonstrated that the interplay between VEGF and Nrp1 is also involved in the Representative dot plots from flow cytometric analysis of CD8 + T cells from tumor tissues of left) . Each data point represents one animal analyzed in one or two (CD69) experiments, respectively. Error bars represent ±SEM. Horizontal bars show the mean. *, P < 0.05; ***, P < 0.001 (Student's t test).
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Next, we asked whether ablation of Nrp1 expression in T reg cells impairs tumor development in vivo. Therefore, we transplanted the established mouse metallothionein I promoterenhancer (MT)/rearranged during transfection (ret) melanoma cell line (Nasarre et al., 2009 ) into Nrp1WT and Nrp1KO mice and measured tumor growth at indicated time points (Fig. 2 A) . As shown in Fig. 2 A, tumor growth was significantly reduced in Nrp1KO mice in comparison to Nrp1WT mice (Fig. 2 A) . When we compared the amount of CD8 + effector T cells within the tumors, we no ticed an increase at day 11 and a significant upregulation at day 14 post transplantation (p.t.) in Nrp1KO mice (Fig. 2 B , left) but no alteration within the draining LNs (dLNs; Fig.  2 B, right) . Importantly, the percentage of activated CD8 + T cells determined by CD69, CD44, Granzyme B, and IFN expression was significantly enhanced at day 14 p.t. in tumors of Nrp1KO mice (Fig. 2 C) , whereas the activation status of CD8 + T cells in the dLN was not affected (Fig. 2 D) .
Subcutaneous transplantation of tumor cells is a well estab lished and commonly used method in cancer research. How ever, transplantation of tumor cells does not reflect the complex developmental and growth characteristics of spontaneously arising tumors and also triggers inflammatory processes caused Fig. 1 A) . To define how Nrp1 expression contributes to T reg cell function during tumorigenesis, we made use of Nrp1 flox/flox mice allowing selective ablation of Nrp1 expres sion in T cells by crossing them with CD4cre mice. Nrp1 expression in CD4 + T cells of secondary lymphoid organs was significantly reduced from 23% in spleen and 14% in mesen teric LNs (mLN) of Nrp1WT mice to <1% in Nrp1 flox/flox × CD4cre mice (Nrp1KO; Fig. 1 B) . Depletion of Nrp1 ex pression using CD4cre mainly affects CD4 + CD25 + T reg cells, as 80% of CD4 + CD25 + T reg cells from secondary lymphoid organs of Nrp1WT mice expressed Nrp1 but only 1-2% of T reg cells from Nrp1KO mice (Fig. 1 C) . Nrp1 expression was also significantly reduced in CD4 + CD25  T cells from 13 or 4% in spleen or mLN, respectively, to 1% in Nrp1KO mice (Fig. 1 D) . Ablation of Nrp1 expression in Nrp1KO mice was specifically restricted to CD4 + T cells, as only a minor population of CD8 + T cells (1%) from Nrp1WT mice expressed Nrp1 and Nrp1 expression on CD11c + , CD11b + , CD8 + , CD19 + , and NK1.1 + splenocytes was not af fected in Nrp1 flox/flox × CD4cre mice (Fig. 1 E) . These re sults show that crossing of CD4cre mice with Nrp1 flox/flox mice leads to specific ablation of Nrp1 expression in CD4 + T cells, in particular CD4 + CD25 + T reg cells. (E) CD69-expressing cells on gated CD8 + T cells were determined in tumors (n = 5 mice) and LN (n = 3 mice) of Ret-and Nrp-1KOxRet-transgenic mice by flow cytometry. Representative dot plots are shown on the left, and summarized results as mean ± SEM of n = 3-5 mice analyzed in three independent experiments are on the right. *, P < 0.05; ***, P < 0.001 (Student's t test).
tumor tissue did not significantly differ between Ret and Nrp 1KOxRet mice (Fig. 3 C) , but a more detailed analysis using immunohistochemistry revealed an increase in intratumoral, but not peritumoral, CD8 + T cells (Fig. 3 D) . The amount of CD4 + and CD8 + T cells within the LNs did not change (Fig. 3 C) . Similar to the results obtained from transplantation experiments (Fig. 2) , the delay in tumor development and the reduction of tumor incidence correlated with a significant increase in activated CD8 + T cells within tumors, but not LNs, of Nrp1KOxRet mice as determined by the expression of CD69 (Fig. 3 E) . Thus, T cell-specific ablation of Nrp1 expres sion impairs the development of tumors by reestablishing the CD8 + T cell-mediated antitumor immune response.
by injection per se. Therefore, we additionally analyzed the effect of T cell-specific Nrp1 ablation in MT/ret (Ret) trans genic mice, which develop spontaneously cutaneous malignant melanoma and metastases in distant organs (Kato et al., 1998; Helfrich et al., 2010) . Remarkably, the onset of tumor devel opment in Nrp1KO mice crossed with MT/ret mice (Nrp 1KOxRet) was significantly delayed (mean = 121 d) in contrast to Ret transgenic mice (mean = 24 d; Fig. 3 A) . Furthermore, Nrp1KOxRet mice developed many fewer tumors over time (Fig. 3 B) . Flow cytometry analysis of tumorinfiltrating lym phocytes (TILs) revealed that the percentage of CD4 + TIL was significantly reduced within tumors of Nrp1KOxRet mice (Fig. 3 C) . The frequency of CD8 + T cells within the whole Results from two to three independent experiments performed in triplicate were summarized with respect to CD4 + CD25  WT T cells (set as 100%) ± SEM. (G) CD8 + T cells were sorted from CD45.1 + WT mice, labeled with CFSE, and either cultured alone (gray bars) or co-cultured with CD45.2 + CD4 + CD25 + T reg cells from Nrp-1WT (white bars) or Nrp-1KO (black bars) in the presence of anti-CD3 and irradiated splenocytes. Proliferation was assessed at day 3 by loss of CFSE on gated CD45.1 + CD8 + responder T cells. Histograms of one out of two independent experiments are shown on the left and data are summarized as mean ± SEM with respect to CD8 + responder T cells (set as 100%; right). ***, P < 0.001 (Students t test).
T reg cells compared with WT CD4 + CD25 + T reg cells (Fig. 4 , E and F). Moreover, CD4 + CD25  T cells and CD4 + CD25 + T reg cells from spleens of Nrp1WT and Nrp1KO mice exhibited similar proliferative activity upon stimulation in vitro and produced equal amounts of the proinflammatory cytokines IL2, IFN, and TNF upon stimulation in vitro (unpublished data). As we observed an increased activation of CD8 + TILs in tumorbearing Nrp1KO mice (Fig. 2 C) , we asked whether Nrp1-deficient T reg cells are able to suppress the proliferation of CD8 + T cells. For this purpose, we performed coculture experiments with CFSElabeled congenic CD8 + T cells from CD45.1 + WT mice and CD45.2 + CD4 + CD25 + T reg cells isolated either from Nrp1WT or from Nrp1KO mice (Fig. 4 G) . By this approach, we could demonstrate that Nrp1-deficient CD4 + CD25 + T reg cells inhibited the proliferation of CD8 + T cells to a similar extent as CD4 + CD25 + T reg cells from WT mice (Fig. 4 G) . These results demonstrate that Nrp1 expression by CD4 + effector T cells does not modulate their susceptibility to T reg cell-mediated suppression and, more importantly, Nrp1
Depletion of Foxp3 + T reg cells results in impaired tumor growth similar to Nrp-1 flox/flox × CD4-cre mice T cell-specific ablation of Nrp1 by using Nrp1 flox/flox × CD4cre mice mainly affects Foxp3 + T reg cells as only a minor population of CD4 + CD25  T cells from WT mice expresses Nrp1 (Fig. 1) . Therefore, we hypothesized that the impaired tumor growth observed in Nrp1 flox/flox × CD4cre was based on modulation in the biological properties of Foxp3 + T reg cells. Most recently, it has been demonstrated that tumor growth of transplanted B16 melanoma cells could be reduced by depletion of Foxp3 + T reg cells after tumor transplantation using transgenic depletion of T reg cells (DEREG) mice, which express a diphtheria toxin (DT) re ceptor under control of the foxp3 locus (Klages et al., 2010) . To analyze whether this finding corresponds to our MT/ret melanoma transplantation model, we depleted Foxp3 + T reg cells from DEREG mice by application of DT and trans planted MT/ret cells. As shown in Fig. 4 A, Foxp3 + T reg cell-deficient mice (DTtreated DEREG mice) exhibited a significantly impaired tumor growth rate at day 11 p.t. In ad dition, we detected a significant expansion of tumorinfiltrating CD8 + T cells (Fig. 4 B) . This effect was specifically caused by the depletion of Foxp3 + T reg cells as application of DT to WT mice had no influence on tumor development or the frequency of CD8 + TILs (Fig. 4 , A and B). These results highlighted in accordance to our MT/ret melanoma cell trans plantation model the crucial role of Foxp3 + T reg cells for tumor growth and progression. More importantly, depletion of Foxp3 + T reg cells resulted in an impaired tumor growth of transplanted MT/ret melanoma cells to a similar extent as in mice with T cell-specific ablation in Nrp1 expression.
Nrp-1 is not essential for the suppressive activity of CD4 + CD25 + T reg cells in vitro
Based on these results, we wondered whether T cell-specific ablation of Nrp1 expression influences their development and/or suppressive phenotype, leading to CD8 + T cell acti vation and impaired tumor growth as observed in our tumor models. Analysis of CD4 + CD25 + and Foxp3 + T reg cells re vealed no differences in their overall percentage in Nrp1KO and Nrp1WT mice (Fig. 4 C) . Moreover, CD4 + CD25 + and CD4 + CD25  T cells from Nrp1KO and Nrp1WT mice expressed similar amounts of Foxp3 as analyzed by flow cytometry (Fig. 4 D) . In addition, we detected no differences in CD4 + and CD8 + T cell distribution in thymus and sec ondary lymphoid organs of both mouse strains (unpublished data) . To analyze the inhibitory capacity of Nrp1-deficient CD4 + CD25 + T reg cells, we performed coculture experi ments with sorted CD4 + CD25  T cells isolated from either Nrp1WT (Fig. 4 E) or Nrp1KO mice (Fig. 4 F) and sorted CD4 + CD25 + T reg cells from Nrp1WT mice and Nrp 1KO mice at different ratios. CD4 + CD25 + T reg cells from Nrp1WT mice led to decreased proliferative responses of CD4 + CD25  T cells both isolated from Nrp1WT and Nrp 1KO mice. Noteworthy, we did not observe any differences in the suppressive activity of Nrp1-deficient CD4 + CD25 + . Nrp-1  (WT; white bars; A) or Nrp-1 + cells (black bars; A), or freshly isolated CD4 + CD25 + T reg cells from Nrp-1WT mice (white bars; C) or Nrp-1KO mice (black bars; C) were seeded in the upper chamber of a transwell system. The lower chamber contained medium alone (negative control), recombinant VEGF, or recombinant SDF as positive control. The migration index was calculated with regard to cell number counted in the lower chamber of negative control (set as 1). Results from two to three independent experiments are depicted as mean ± SEM. *, P < 0.05 (Student's t test). (B) Expression levels of CD25 and Nrp-1 on isolated CD4 + CD25 + T reg cells from Nrp-1WT and Nrp-1KO mice were determined by flow cytometry.
Nrp1KO mice by cell sorting. The majority (80%) of sorted CD4 + CD25 + T reg cells from Nrp1WT mice ex pressed Nrp1, whereas we detected only 1% of Nrp1 + cells within the sorted CD4 + CD25 + T reg cells from Nrp1KO mice (Fig. 5 B) . As shown in Fig. 5 C, both cells types mi grate toward SDF (positive control), but Nrp1-expressing CD4 + CD25 + T reg cells from Nrp1WT mice exhibited a significantly increased migratory activity toward VEGF com pared with Nrp1-deficient CD4 + CD25 + T reg cells. Thus, we concluded that Nrp1 is required for T cell migration to ward VEGF in the in vitro situation.
To analyze the impact of the VEGF-Nrp1 signaling axis on the infiltration of Nrp1-expressing Foxp3 + T reg cells into tumors in vivo, we addressed the impact of tumor cellderived VEGF during this process. Therefore, we made use of a murine fibrosarcoma cell line with a homozygous dele tion of the vegfa gene (VEGF / ), as well as the correspond ing VEGFexpressing WT fibrosarcoma cells (VEGF +/+ ; Stockmann et al., 2008) . First, we analyzed the VEGF mRNA expression level in tumor tissues from Ret and Nrp1KOxRet mice, as well as in the MT/ret tumor cell line, the WT (VEGF +/+ ), and the VEGFdeficient fibrosarcoma cells (VEGF / ). We observed no significant differences in VEGF expression in Nrp1KOxRet tumors compared with Ret tumors and identified the established MT/ret cell line as a source of high VEGF expression compared with the VEGF +/+ fibrosarcoma cell line (Fig. 6 A, left) . As expected, VEGF / fibrosarcoma cells did not express VEGF. Besides VEGF, expression by CD4 + CD25 + T reg cells is not required for their inhibitory function in vitro. This finding was somehow surprising, as we observed an increased activation of CD8 + T cells within transplanted tumors from Nrp1KO mice in comparison to Nrp1WT mice (Fig. 2) , which suggests dif ferences in the immunosuppressive function of WT T reg cells and Nrp1-deficient T reg cells. Therefore, Nrp1 ex pression seems to contribute to the complex biological prop erties of T reg cells not directly through a modulation of their suppressive capacity.
Tumor-derived VEGF contributes to Nrp-1 + Foxp3 + T reg cell infiltration into the tumor An effective immunosuppression in vivo requires an appro priate colocalization of suppressor and effector cells, and in creased numbers of CD4 + CD25 + T reg cells is a characteristic feature of several tumor entities (Zou, 2006) . Because Nrp1 regulates the directed migration of various cell types (Wang et al., 2003; Schwarz et al., 2004; Murga et al., 2005) , we asked whether Nrp1 is involved in the migratory potential of T reg cells with respect to the Nrp1 ligand VEGF. There fore, we performed an in vitro transwell migration assay with an Nrp1-deficient T cell hybridoma line (Weber et al., 1992 ) that served as WT and an Nrp1-expressing mutant (Nrp1 + ) that was generated by transduction of a Nrp1 en coding retroviral vector (Fig. 5 A) . Both WT and Nrp1 + cells were able to migrate through transwell in response to stromal cell-derived factor (SDF; positive control) to the same degree, but only Nrp1 + cells exhibited migratory ac tivity toward recombinant VEGF, whereas Nrp1 deficiency completely abolished the migration of T cells in response to VEGF (Fig. 5 A) . To further corroborate these results, we isolated CD4 + CD25 + T reg cells from Nrp1WT and Results from two independent experiments with n = 2-3 mice per group and experiment are depicted as mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Student's t test).
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Role of Nrp-1 on T reg cells during melanoma | Hansen et al. tumorderived VEGF. To analyze this in more detail, we subcutane ously transplanted VEGF +/+ or VEGF / fibrosarcoma cells to Nrp1KO and Nrp1WT mice. As assumed, transplanta tion of VEGF +/+ cells into Nrp1WT mice resulted in the highest tumor volumes (Fig. 6 B) . However, we observed a similar reduction in tumor growth in Nrp1KO mice trans planted with VEGF +/+ cells or VEGF / cells and Nrp1WT mice transplanted with VEGF / cells compared with Nrp 1WT mice that received VEGF +/+ cells (Fig. 6 B) . More over, the absence of VEGF expression in tumor cells and ablation of Nrp1 in T cells of the host had no additive effect on tumor growth retardation. Consistent with the tumor growth rates, deletion of tumorderived VEGF (VEGF / ) or ablation of T cell-specific Nrp1 expression in the host (Nrp1KO) resulted in increased numbers of intratumoral CD8 + T cells that exhibited a more pronounced activation status as determined by the expression of CD69 in compari son to the Nrp1WT mice transplanted with VEGF +/+ fibro sarcoma cells (Fig. 6, C and D) . Interestingly, we detected an TGF and Semaphorin 3A (Sema 3A) are also known to interact with Nrp1 and, thereby, might contribute to the impaired tumor growth in mice with T cell-specific Nrp1 ablation. Interestingly, we detected a significant increase in TGF mRNA expression in tumors from Nrp1KOxRet mice compared with tumors from Ret mice, but no signifi cant differences in the TGF expression in VEGF +/+ fibro sarcoma cells when compared with VEGF / fibrosarcoma cells (Fig. 6 A, middle) . Additionally, similar levels of Sema 3A were expressed in tumor tissues from Nrp1KOxRet mice compared with Rettransgenic tumors, and in both fibrosar coma cell lines (Fig. 6 A, right) .
As we have demonstrated that Nrp1-expressing CD4 + CD25 + T reg cells from WT mice have the capacity to migrate toward VEGF in contrast to Nrp1-deficient CD4 + CD25 + T reg cells in vitro, we hypothesized that Nrp1 expressed by the majority of WT CD4 + CD25 + T reg cells is involved in T reg cell tumor infiltration in dependency on Representative dot plots from one flow cytometric analysis out of two independent experiments with n = 2-4 mice (per group and experiment; left) and summarized data are shown as mean ± SEM (right). *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Student's t test).
(day 11 p.t.) or also modulated at early time points of tumor development, we additionally analyzed tumor tissues at days 1, 2, and 3 p.t. As shown in Fig. 7 C, the number of intratumoral Foxp3 + T cells of Nrp1KO mice bearing either VEGF +/+ or VEGF / fibrosarcoma cell-derived tumors as well as from Nrp1WT mice that received VEGF / fibrosarcoma cells was also significantly reduced at least at day 11 p.t. to a similar level across genotypes in comparison to Nrp1WT mice that were transplanted with VEGF +/+ cells (Fig. 7 C) . Moreover, the majority of tumorinfiltrating Foxp3 + T reg cells from Nrp1WT mice expressed Nrp1 to a similar extent as Foxp3 + T reg cells within the dLNs at different time points p.t. (Fig. 7 D) . The mRNA expression analysis of the Nrp1 ligands VEGF, TGF, and Sema 3A (Fig. 6 A) revealed that only VEGF was differentially ex pressed in VEGF +/+ and VEGF / fibrosarcomas; therefore, it is unlikely that TGF or Sema 3A contribute to the ob served phenotype. Thus, our results strongly suggest that tumorderived VEGF serves as a chemoattractant for Foxp3 + T reg cells and that Nrp1 expression on T reg cells is re quired for their infiltration into tumors. Importantly, disrup tion of VEGF/Nrp1 signaling between tumor cells and T reg cells by ablating either the tumorderived VEGF signal or the Nrp1 receptor on T reg cells prevents T reg cell infil tration into the tumor and impairs tumorigenesis.
Impaired melanoma development is paralleled by the reduction of tumor-infiltrating Foxp3 + T reg cells
Next, we asked whether the Nrp1-dependent infiltration of T reg cells into tumor tissues is restricted to the chosen fibro sarcoma model or a more common mechanism. Therefore, we went back to our melanoma model and studied infiltration and localization of CD4 + T cells and Foxp3 + T reg cells in spontaneously developing tumors of Nrp1KOxRet mice. The CD4 + T cell number was significantly reduced in the increase in the number of intratumoral CD8 + T cells in Nrp 1KO mice after transplantation of VEGF / cells accompa nied with a strong activated phenotype compared with the corresponding Nrp1WT mice (Fig. 6, C and D) . CD8 + T cells isolated from the dLNs of the various fibrosarcoma transplantation models did not exhibit an activated pheno type (Fig. 6 D) . To analyze whether this effect is indeed based on impaired T reg cell infiltration in dependency on VEGF expression by tumor cells and Nrp1 expression by hostderived T cells, we determined the amount of CD4 + T cells and Foxp3 + T reg cells within the tumors and dLNs of Nrp1WT and Nrp1KO mice that received either VEGF +/+ cells or VEGF / cells at day 11 p.t. The number of CD4 + T cells within tumors of mice with either Nrp1-deficient T cells (Nrp1KO) or tumors that do not produce VEGF (VEGF / ), or both, was significantly lower than in VEGFproducing (VEGF +/+ ) tumors from Nrp1WT mice (Fig. 7 A) . More importantly, the percentages of Foxp3 + T reg cells within the tumors are significantly higher in Nrp1WT mice that re ceived VEGF +/+ fibrosarcoma cells than in Nrp1KO mice transplanted with VEGF +/+ fibrosarcomas or Nrp1 WT mice harboring VEGFdeficient tumors (VEGF / ; Fig. 7 B) . The amount of Foxp3 + T reg cells within the dLNs of tumorbearing mice did not change in dependency on tumor produced VEGF or Nrp1 expression in T cells from the host (Fig. 7 B) . To verify whether the number of Foxp3 + T reg cells within the tumors is only affected during tumor progression Nuclei were counterstained using propidium iodide. Quantification for the number of Foxp3 + T cells recruited to the tumor-associated stroma or into the center of Ret (white bars) or Nrp-1KOxRet (black bars) tumors (intratumoral). Data are shown as mean ± SEM from three independent experiments (n = 9-12 tumors from three mice, Ret; n = 6-9 tumors from three mice, Nrp-1KOxRet). Bar, 100 µm. Dotted line: intratumoral vessel. *, P < 0.05; **, P < 0.001; ***, P < 0.0001 (Student's t test).
across the tumor, the localization of Foxp3 + T cells within tumors from Nrp 1KO mice was re stricted to the outer rim of the tumor with almost complete absence of Foxp3 + T cells in the tumor center (Fig. 9 C) . Within the dLNs, we observed no differences in the percent ages of Foxp3 + T reg cells at any time point analyzed (Fig. 9 E) . To verify that tumorinfiltrating Foxp3 + T reg cells coexpress Nrp1 also in our MT/ret transplantation model, we deter mined the percentages of Nrp1 + on Foxp3 + T reg cells. As shown in Fig. 10 A, 70-80% of Foxp3 + T reg cells from tumors and dLNs of Nrp1WT mice transplanted with MT/ret cells expressed Nrp1 at days 3, 5, and 7 p.t., whereas we did not detect Nrp1-expressing Foxp3 + T reg cells in Nrp 1KO mice, as expected (Fig. 10 A) . However, by using the Nrp1 flox/flox × CD4cre (Nrp1KO) mouse model, we not only ablated Nrp1 expression in Foxp3 + T reg cells but also in the small population of Nrp1 + Foxp3  T cells, which might have an influence on tumor growth and progression. Flow cytometry analysis of Nrp1 + CD4 + T cells from tumors and dLN of MT/ret transplanted Nrp1WT mice revealed that 10-30% of Nrp1 + CD4 + T cells did not coexpress Foxp3 and thereby did not represent T reg cells (Fig. 10 B) . To elucidate the effect of Nrp1 ablation in these CD4 + Nrp1 + Foxp3  effector T cells, we made use of an additional transgenic mouse model. We crossed Nrp1 flox/flox mice with intra and peritumoral area of tumorbearing Nrp1KOxRet mice, and intratumoral CD4 + T cells were exclusively associ ated with vascular structures (Fig. 8 A) . Along with this find ing, we detected an impaired infiltration of Foxp3 + T reg cells into tumors of Nrp1KOxRet mice in comparison to Ret mice (Fig. 8 B) . The number of stromaassociated, as well as intratumoral Foxp3 + T reg cells, was significantly reduced in Nrp1KOxRet tumorbearing mice. Moreover, intratumoral Foxp3 + T reg cells from Nrp1KOxRet mice were exclusively located in the lumen of tumorassociated vessels (Fig. 8 B) . Immunohistochemistrybased analysis of Rettransgenic tu mors revealed that the majority (56.7 ± 9.1%) of intratumoral CD4 + T cells expressed Nrp1 (unpublished data). In sum mary, these results provide evidence that Nrp1, expressed by Foxp3 + T reg cells, regulates the infiltration of T reg cells into tumors, thereby enabling a dampened antitumor immune response that allows unrestricted tumor progression.
To characterize the influence of T cell-expressed Nrp1 on the infiltration and localization of CD4 + T cells and Foxp3 + T reg cells at early time points of tumor progression, we ana lyzed the T cells recruited into the tumors and dLN cells of Nrp1WT and Nrp1KO mice transplanted with MT/ret cells at days 1, 2, 3, 5, and 7 p.t. in more detail. The number of tumorinfiltrating CD4 + T cells (Fig. 9 A) and Foxp3 + T reg cells (Fig. 9 D) and the frequency of CD4 + T cells within the dLNs (Fig. 9 B) were significantly reduced in Nrp1KO mice compared with Nrp1WT mice. Strikingly, whereas Nrp1WT mice showed a homogenous distribution of Foxp3 + T cells shown. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Student's t test).
mice. As expected, transplanted Nrp1KO mice that did not receive any cells exhibited a significantly impaired tumor growth compared with Nrp1WT mice. Importantly, Nrp1KO mice that were recon stituted with Nrp1-expressing WT T reg cells showed a sig nificant increase in tumor growth compared with untreated Nrp1KO mice and similar tumor volumes as Nrp1WT mice at day 14 p.t. (Fig. 10 F) . These results further strengthen our conclusion that Nrp1 highly expressed by T reg cells controls infiltration of Foxp3 + T reg cells into tumor tissues in dependency on tumorderived VEGF.
DISCUSSION
Tumor cells are dependent on their local microenvironment for the supply of oxygen, nutrients, survival factors, and sup porting stroma. Moreover, tumor growth requires a com plex interplay between the expanding tissues and several accessory cells, including immune cells. It has been shown that CD4 + CD25 + regulatory T cells are increased in the peripheral blood and tumor microenvironment in differ ent types of cancer (Strauss et al., 2007; Li et al., 2009; Ohara et al., 2009) , suggesting that T reg cells worsen the clinical prognosis. Here, we could demonstrate that depletion of Foxp3-IRES-cre recombinase (FIC) mice, expressing the cre recombinase under control of the foxp3 locus (Wing et al., 2008) . In these FIC × Nrp1 flox/flox mice, Nrp1 expression is specifically ablated in Foxp3 + T reg cells but not in CD4 + Foxp3  T cells (Fig. 10 C) . Transplantation of tumor cells resulted in a significant delay in tumor growth at day 14 p.t. accompanied by an expansion of tumorinfiltrating CD8 + T cells in these T reg cell-specific Nrp1-deficient mice (FIC × Nrp1 flox/flox ) in comparison to FIC × Nrp1 wt/wt mice (Fig. 10, D and E) . Thus, this phenotype resembles the impaired tumor growth that we also observed in mice with T cell-specific Nrp1 ablation (Nrp1KO), suggesting that Nrp1 expression in Foxp3 + T reg cells, but not in Foxp3  T cells, is responsible for this phenotype. Finally, to corrobo rate our observation that Nrp1 is important for the infiltra tion of Foxp3 + T reg cells into VEGFproducing tumor tissues, groups of Nrp1WT mice and Nrp1KO mice were trans planted with MT/ret cells and, additionally, WT T reg cells were adoptively transferred to one group of Nrp1KO Tumor volumes were monitored at days 4, 7, 11, and 14 p.t. and are shown as mean ± SEM from one out of two independent experiments (n = 3-5 mice). (E) The percentages of tumor-infiltrating CD8 + T cells were determined in MT/ret transplanted FIC × Nrp-1 flox/flox mice (black bars) and FIC × Nrp-1 wt/wt mice (white bars) at day 14 p.t. by flow cytometry and summarized as mean ± SEM from two independent experiments (n = 3-5 mice). (F) Nrp-1WT and Nrp-1KO mice were transplanted with MT/ret cells and one group of transplanted Nrp-1KO mice were additionally injected with WT T reg cells. Tumor volumes were monitored at days 4, 7, 11, and 14. Results from four independent experiments with n = 8-11 mice (per group in total) are shown as mean ± SEM. *, P < 0.05; **, P < 0.01 (Student's t test).
Our coculture experiments revealed no differences in the inhibitory capability of Nrp1-expressing T reg cells and Nrp1-deficient T reg cells on neither CD4 + nor CD8 + responder cells. Consistent with our results, human Nrp1 + T reg cells exhibited suppressive activity in vitro, but the ad dition of blocking anti-Nrp1 antibodies did not alter their inhibitory capability (Battaglia et al., 2008) . Although Nrp1 does not seem to be critical for the intrinsic immune suppressive function of T reg cells in our hands, we observed a striking phenotypic difference in Nrp1KO mice when studying tumorigenesis. In contrast to the fixed microenvi ronment in the in vitro culture system, immunosuppression in vivo requires the appropriate colocalization of suppressor and effector T cells (von Boehmer, 2005) ; therefore, in vivo T reg cells must be able to migrate into tissues to physically interact directly with effector cells or indirectly via antigen presenting cells. As Nrp1 has been described to be involved in migration and/or adhesion of endothelial cells (Wang et al., 2003; Murga et al., 2005) , we hypothesized that Nrp1 expressed by Foxp3 + T reg cells contributes to migration of T reg cells toward tumorderived VEGF.
It is well established that CD4 + CD25 + T reg cells play a crucial role in the regulation of antitumor immune responses (Zou, 2006) , and increased numbers of T reg cells were de tected in different tumors (Wada et al., 2009 ). Interestingly, Battaglia et al. (2008) have demonstrated that the amount of Nrp1 + T reg cells in dLNs of cervical cancer patients directly correlated with the disappearance of the primary tumor mass upon chemoradiation therapy. Furthermore, data from a patient with ovarian cancer during therapy revealed a direct correlation between the amount of T reg cells and VEGF concentration in malignant effusions (Wada et al., 2009 ). Gupta et al. (2007) likewise described a positive, although not significant correlation of intratumoral T reg cells with VEGF in breast cancer. Vice versa, blocking of VEGF by administra tion of antiVEGF antibodies significantly reduced the amount of Foxp3 + T reg cells in an inflammatory breast cancer model (Roland et al., 2009) . Together, these studies suggest that tumorderived VEGF chemoattracts Foxp3 + T reg cells via Nrp1. Indeed, in an in vitro migration assay, we could demonstrate that Nrp1 + T reg cells from WT mice, but not Nrp1-deficient T reg cells from Nrp1KO mice, exhibited migratory activity toward VEGF. Moreover, T cell-specific ablation of Nrp1 expression resulted in delayed tumor growth in a tumor transplantation model as well as in our spontaneous MT/ret melanoma model accompanied by reduced numbers of Foxp3 + TILs in contrast to tumordeveloping WT mice. Thus, our detailed analysis of Nrp1-deficient T reg cells in vitro argues that Nrp1 expression is not directly involved in their intrinsic suppressive mode of action but confers mi gratory activity into inflamed tissue sites that release VEGF. This mechanism is then exploited by inflammatory tumors to attract immuneinhibitory cells like Nrp1-expressing Foxp3 + T reg cells into the tumor and to overcome antitumor immunity.
Besides VEGF two other molecules, namely TGF and Sema 3A, have been described to interact with the Nrp1 Foxp3 + T reg cells from tumorbearing mice indeed signifi cantly reduced tumor growth. The infiltration of Foxp3 + T reg cells into the tumor site to locally suppress an effective antitumor response is supposed to be one of the main obsta cles in regulating tumor immune escape. However, the pre cise mechanism by which T reg cells infiltrate into the tumor remains unknown as well as its exact functional role in mod ulating the interaction between immune system and tumor.
Recently, we have identified the VEGF coreceptor Nrp1 as a suitable surface marker for the identification of CD4 + CD25 + T reg cells, whose expression is regulated by the T reg cell-specific transcription factor Foxp3 (Bruder et al., 2004; Loser et al., 2005) . To gain mechanistic insights regard ing Nrp1 function on T reg cells in particular during tu morigenesis, we made use of Nrp1 flox/flox × CD4cre mice (Nrp1KO) to specifically ablate Nrp1 expression in T cells. By using these transgenic mice, we could show for the first time that knockdown of Nrp1 expression in T cells, mainly Foxp3 + T reg cells, results in a significant breakdown of tumor immune escape in several murine melanoma models and a fibrosarcoma model accompanied by reduced tumor growth and, interestingly, prolonged tumorfree survival in a T cellspecific Nrp1-deficient spontaneous mouse melanoma model. We observed altered immune cell recruitment associated with decreased numbers of infiltrating Foxp3 + T reg cells into the tumor site by a disconnection in Nrp1-dependent migration in response to tumorderived VEGF. This entire process re sulted in a compensatory enhanced activation of recruited CD8 + T cells within these tumors, suggesting that Nrp1 ab lation in Foxp3 + T reg cells contributes to a more effective antitumor response. Analysis of Foxp3 + T reg cells in the peripheral lymphoid organs revealed no differences in the amount of Foxp3 + T reg cells in naive and tumorbearing Nrp1KO (Nrp1 flox/flox × CD4cre mice) and WT mice. Consistent with these results, Solomon et al. (2011) also detected similar amounts of Foxp3 + T reg cells in both Nrp1 flox/flox × CD4cre mice and WT mice, suggesting that the observed differences in tumorigenesis are not a result of overall reduced numbers of Foxp3 + T reg cells in these mice.
Most recently, it was proposed that Nrp1 promotes long interactions between T reg cells and immature DCs (iDCs; Sarris et al., 2008) , which are thought to play a crucial role in the maintenance of selftolerance by presenting selfantigens and inducing unresponsiveness of T cells. However, upon maturation of DCs by LPS interactions of naive T cells to mature DCs were comparable to those of T reg cells (Sarris et al., 2008) . This observation suggests that Nrp1 confers a relatively high adhesive property on T reg cells in their inter action with iDCs under steady state, but T reg cells loose this advantage over naive T cells under inflammatory conditions (Mizui and Kikutani, 2008) . Thus, during tumorigenesis it is unlikely that the proposed function of Nrp1 on T reg cells by Sarris et al. (2008) is the main underlying mecha nism of delayed tumor growth in Nrp1KO mice. There fore, we investigated the effect of Nrp1 ablation on the intrinsic immunesuppressive function of T reg cells in vitro.
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In further studies, it has to be clarified whether Nrp1-mediated migration of Foxp3 + T reg cells is a special mechanism active during tumorigenesis or a fundamental process also occurring during other VEGFdependent disease settings. It is well known that VEGF expression is extensively increased in mice suffering from experimental autoimmune encephalomy elitis (EAE), a mouse model for multiple sclerosis (MS). Fur thermore, the level of VEGF expression positively correlates with the clinical score in the EAE model (Roscoe et al., 2009) as well as in patients with acute and chronic MS (Proescholdt et al., 2002) . Most recently, Solomon et al. (2011) observed an increase in the clinical score of EAE diseased Nrp1 fl/fl × CD4 cre (Nrp1KO) mice in contrast to WT mice, owing at least in part to a decreased intrinsic T reg cell functionality. However, one might also speculate about disrupted VEGFdependent chemoattraction of Nrp1-deficient Foxp3 + T reg cells to the central nervous system, leading to uncontrolled proinflamma tory immune responses and thereby contributing to a more exacerbated EAE severity in Nrp1KO mice.
In summary, our results provide for the first time evidence that Nrp1 expression is critically required for the infiltration of Foxp3 + T reg cells into VEGFproducing tumors and that blocking this process reestablishes the antitumor immune response, resulting in impaired tumor progression. This might open up new therapeutic strategies in oncology that aim to interfere with the chemoattraction of Nrp1 + T reg cells toward VEGF not only during tumorigenesis but possibly also in various other VEGFdependent diseases like MS.
MATERIALS AND METHODS
Mice. Nrp1 flox/flox mice (provided by D.D. Ginty, John Hopkins University, Baltimore, MD; Gu et al., 2003) , CD4cre mice (provided by W. Müller, University of Manchester, Manchester, UK), FIC mice (Wing et al., 2008) , DEREG mice (Lahl et al., 2007) , C57/BL6 mice (Harlan), and MT/ret mice (provided by M. Kato, Chubu University, Aichi, Japan) were crossed and maintained under specific pathogenfree conditions at the Animal Facility of the University Hospital Essen. Heterozygous MT/ret mice express the human ret protooncogene under the control of MT/ret and develop spon taneously cutaneous malignant melanoma with metastases to distant organs that resemble human melanoma in many aspects of histopathology and clini cal development (Kato et al., 1998) . All animal experiments were performed in accordance with government and institute guidelines and regulations. Animal procedures were approved by the state authorities for Ethics in Ani mal Experiments of NorthRhine Westphalia, Germany.
Tumor transplantation. Immortalized and transformed VEGF +/+ and VEGF / mouse fibrosarcoma cells and MT/retderived tumor cells were generated as described previously (Stockmann et al., 2008; Nasarre et al., 2009) . VEGF +/+ or VEGF / fibrosarcoma cells (5 × 10 6 ), MT/ret cells (5 × 10 5 ), or CT26 tumor cells (5 × 10 5 ) suspended in 100 µl Matrigel (BD)/PBS (1:1) were injected s.c. in the left flanks of 6-8wkold mice. For the adoptive transfer experiment, 10 6 sorted CD4 + CD25 + T reg cells from WT mice in a total volume of 100 µl PBS or equal volume of PBS alone (as control) were injected i.v. directly before s.c. tumor cell trans plantation. For CD4 + Foxp3 + T reg cell depletion, DEREG mice were injected i.p. with 30 ng/g body weight of DT (Merck) 1 d before tumor transplantation and at days 2, 5, and 8 p.t. Tumor volume was quantified by caliper measurement at days 3, 7, and 11 (length × width × height). Mice were sacrificed at the indicated time points or when the first tumor within an experimental group had grown to 2 cm 3 .
receptor Glinka and Prud'homme, 2008) . As different tumors also produce TGF and Sema 3A (Catalano et al., 2006; Busse and Keilholz, 2011) , one might speculate that both molecules contribute to the attraction of Nrp1-expressing Foxp3 + T reg cells into the tumor tissue.
However, we could demonstrate that ablation of VEGF in fibrosarcoma cells (VEGF / ) resembles a similar phenotype, including reduced tumor growth, increased activation of CD8 + TILs, and reduced numbers of intratumoral Foxp3 + T reg cells as observed in T cell-specific Nrp1-deficient mice transplanted with WT (VEGF +/+ ) fibrosarcoma cells. Realtime PCR analysis revealed no significant differences in the expression of TGF and Sema 3A in VEGFdeficient (VEGF / ) and VEGF WT (VEGF +/+ ) fibrosarcoma cells. In addition, we detected decreased numbers of Foxp3 + T reg cells within tumors from Nrp1KOxRet mice in contrast to Ret mice and again Sema 3A mRNA expression levels were not altered in tumors from both mouse lines. TGF mRNA expression was significantly increased in tumor tissues iso lated from Nrp1KOxRet mice compared with Ret mice. However, if one assumes that TGF contributes to Foxp3 + T reg cell infiltration into the tumor in dependency on Nrp1, one would expect more but not fewer numbers of tumor infiltrating Foxp3 + T reg cells in T cell-specific Nrp1-deficient Ret (Nrp1KOxRet) mice. Thus, from our results it is unlikely that Foxp3 + T reg cell infiltration into the tumor is directly dependent on tumorexpressed Sema 3A and TGF but rather is regulated by tumorderived VEGF.
Nrp1 is not only highly expressed by Foxp3 + T reg cells because Nrp1 expression has been detected in various human carcinoma cell lines and primary tumors (Staton et al., 2007) , including tumor cells from melanoma patients them selves. Overexpression of Nrp1 promotes tumor cell growth in vitro whereas antibodymediated Nrp1 blockage resulted in tumor growth inhibition (Pan et al., 2007) . Moreover, Straume and Akslen (2003) demonstrated that an increased expression of VEGF receptors, including Nrp1, was associ ated with glomeruloid microvascular proliferation, represent ing an aggressive angiogenic phenotype in patients suffering from malignant melanoma. With regard to the Nrp1 ligand VEGF, it was shown that overexpression of VEGF in mela noma cells that express its receptors, including Nrp1, led to increased growth and survival of melanoma cells through MAPK and PI3K signaling (Graells et al., 2004) . Whether Nrp1-VEGF interaction in Foxp3 + T reg cells activates this pathway and thereby contributes to an increased survival of intratumoral T reg cells has to be clarified in further studies. However, results from our study provide evidence that Nrp1 expressed by Foxp3 + T reg cells contributes to their migra tion into tumor tissues in dependency of tumorderived VEGF leading to local suppression of an adequate antitumor immune response. Thus, Nrp1-VEGF interaction affects different processes that are important during tumorigenesis including angiogenesis, tumor cell growth, and survival and, as demonstrated in this study, chemoattraction of immuno suppressive Foxp3 + T reg cells. calculated for all ROI. All analyses were performed on microscopes (Olym pus) and corresponding Cell P Software. Slides fluorescence was examined by confocal laserscanning microscopy (TCS SP2; Leica).
Migration. 16.2.11 hybridoma cells (Weber et al., 1992) were infected with a retroviral vector encoding Nrp1 cDNA (provided by H. Fujisawa, Nagoya University, Nagoya, Japan) as described previously (Reinwald et al., 2008) . Migration assays were performed using transwell chambers with 5 µm poly carbonate filters (Costar) as previously described (Heuer et al., 2006) . In brief, 100 ng/ml recombinant VEGF or SDF1 (Tebu) diluted in migration assay media or as negative control assay media alone was added to the lower cham ber of the transwells. The fibronectincoated transwell inserts were placed on top, and 10 6 16.2.11 cells, retroviral transduced 16.2.11 hybridoma cells, or 10 6 CD4 + CD25 + T reg cells from either Nrp1WT or Nrp1KO mice were added to the upper chamber. After 2.5-3.5 h of incubation at 37°C, cells that had migrated through the filter were collected and counted.
X-ray computed tomography. Mice were mask narcotized using Iso flurane (Abbott). A thinslice xray computed tomography (CT) of mice was performed using Dual Source CT (SOMATOM Definition; Siemens). Ultrathin 0.4 mm slices covering the whole body were acquired and calcu lated in window center 50 and window width 350. A threedimensional reconstruction was made in volume rendering technique to visualize the surface of each animal in 19 standardized planes.
Statistical analysis. Student's t test was used for the determination of statis tical significance between experimental groups. Results were expressed as mean ± SEM. P values <0.05 were considered statistically significant.
RNA isolation and quantitative real-time PCR. RNA isolation from can cer cell lines and tumor biopsies was performed by using Qiazol Lysis Reagent (QIAGEN) according to the manufacturer's instructions including DNase I treatment (Fermentas). Afterward, 1 µg of each sample was reverse transcribed using RevertAid H Minus First strand cDNA Synthesis kit in a final volume of 20 µl (Fermentas). Realtime PCR was performed in an ABI PRISM cycler (Life Technologies) with a SYBR Green PCR kit from Applied Bio systems (Life Technologies) and specific primers for VEGF (5ATCCGCAT GATCTGCATGG3 and 5AGTCCCATGAAGTGATCAAGTTCA3), TGF- (5ACCTGGGTTGGAAGTGGAT3 and 5GAAGCGCCC GGGTTGTGTTGGTT3), Sema3A (5CAAAGGCAAGCTGAATG GAT3 and 5AGAGCTAGAAAGAAATGGGAGAGT3), and RPS9 (5CTGGACGAGGGCAAGATGAAGC3 and 5TGACGTTGGCG GATGAGCACA3). Relative mRNA levels were determined by using in cluded standard curves for each individual gene and further normalization to the housekeeping gene RPS9, as described previously (Hansen et al., 2007) .
Flow cytometry. Flow cytometric expression analyses were performed using anti-mouse CD4 (L3T4), CD8 (Ly2), CD25 (PC61), CD69 (H1.2F3), CD44 (IM7), CD11c (HL3), CD11b (M1/79), CD19 (1D3), NK1.1 (PH136; all BD), and anti-Nrp1 (R&D Systems) as Pacific blue, FITC, allophycocyanin, or Phycoerythrin conjugates. Alternatively, unconjugated goat anti-Nrp1 antibody (R&D Systems) was used, followed by incubation with Alexa Fluor 647-conjugated anti-goat antibody (Invitrogen). Intra cellular staining was performed using the Foxp3 staining kit from eBiosci ence (NatuTec) with antiFoxp3 (FJK16s) or anti-granzyme B (GB11) according to the manufacturer's recommendations. IFN expression was analyzed by stimulating cells for 4 h with 10 ng/ml PMA (Sigma Aldrich) and 100 µg/ml ionomycin (SigmaAldrich) in the presence of 5 µg/ml Brefeldin A (SigmaAldrich), treated with 2% paraformaldehyde and 0.1% NP40 and stained with anti-mouse IFN (XMG1.2, BD). FACS analyses were performed with LSRII and DIVA software (BD).
Cell separation. CD4 + T cells, enriched from splenocytes by using the CD4 + T cell isolation kit (Miltenyi Biotec) according to the manufacturer's recommendations, or whole erythrocytedepleted splenocytes were labeled with antiCD4 (L3T4; BD) and antiCD25 antibodies (PC61; BD). CD4 + CD25 + and CD4 + CD25  were separated using a MoFlow (Cytoma tion) or FACSAria II (BD) and purity was >97%. Tumors were removed from animals, cut in small pieces, crushed through a 100µm nylon mash, and depleted of erythrocytes before staining with different antibodies for flow cytometric analysis.
Proliferation. 10 5 sorted CD4 + CD25 + T cells and CD4 + CD25  T cells were either cultured alone or cocultured with CD4 + CD25  responder T cells at different ratios in the presence of 1 µg/ml antiCD3 and irradiated splenocytes as APCs (4 × 10 5 ) for 72 h. Proliferation and suppression assays were performed in triplicate in a final volume of 200 µl. Cells were pulsed with 1 µCi/well of [ 3 H]thymidine for the final 8-18 h of the experiment and [ 3 H]thymidine incorporation was measured by scintillation counting. Alternatively, 10 5 sorted CD45.1 + CD8 + T cells were labeled with CFSE and cultured alone or cocultured with 10 5 CD4 + CD25 + T cells from CD45.2 + Nrp1KO or Nrp1WT mice in the presence of 1 µg/ml antiCD3 and irra diated splenocytes as APCs (4 × 10 5 ) for 72 h. Proliferation of CD45.1 + CD8 + responder cells was assessed as loss of CFSE dye by flow cytometry.
Immunohistochemical-based analyses. Consecutive cryosections (7 µm) were stained using rat anti-Foxp3FITC (NatuTec), rat antiCD4 (BD), rab bit antiCD8 (Abcam), goat anti-Nrp1 (R&D Systems), and corresponding IgG as control (Dianov) as previously described (Helfrich et al., 2010) . Nuclei were stained using propidium iodide (Merck). Quantification of individual cell populations (CD8 + , CD4 + , Foxp3 + , and Nrp1 + ) per tumor area (mm 2 ) was calculated using the mean of three tumor sections per tumor (top, middle, and base) of concordant distance at indicated time points. A total of five regions of interest (ROI) per tumor section were evaluated. Means were
